Nigerian Company Procures Implant Sciences’ Handheld Explosives Trace Detectors

Implant Sciences Corporation, a high technology supplier of systems and sensors for homeland security and defense markets, today announced it has sold three more Quantum Sniffer™ QS-H150 handheld explosives trace detectors to a corporate customer for critical infrastructure protection in Nigeria.

This marks the fifth sales contract in the African nation in the past six months. This was the second sale made by Implant Sciences' in-country Nigerian distributor, AC Belgrave. Recent sales in Nigeria have included deployment for airline catering and hotels.

"We've experienced a rapid expansion in our sales since the first QS-H150 was sold into the country just months ago. The unfortunate growing threat from terrorist groups has created a need for high security at commercial and governmental buildings. The Quantum Sniffer can play a growing role in this security environment," stated Darryl Jones, Implant Sciences' Vice President of Sales and Marketing.

"In a similar trend to what we have experienced in China, initial sales of our Quantum Sniffers are quickly generating a positive reputation for reliability and accuracy in Africa. Thanks to our dedicated local distributors' superior sales and customer service capabilities, we are able to deliver high-quality, high-performance, made in the U.S.A. equipment to our international customers. We anticipate continued growth in the African continent," added Glenn D. Bolduc, Implant Sciences' President and CEO.

About the Quantum Sniffer™ QS-H150 Handheld Explosives Trace Detector

The Quantum Sniffer QS-H150 utilizes Ion Mobility Spectrometry (IMS) technology, providing fast, accurate detection of trace amounts of a wide variety of military, commercial, and homemade explosives. Built with no radioactive materials and featuring a low-maintenance, self-calibrating, and self-clearing design, the QS-H150 provides very high levels of operational availability. The QS-H150 has been proven to perform well in a wide variety of temperatures and challenging environments, from humid jungles to dry, sand swept deserts.

About Quantum Sniffer™ QS-B220 Desktop Explosives & Drugs Trace Detector

The Quantum Sniffer QS-B220 uses Ion Mobility Spectrometry (IMS) to rapidly detect and identify trace amounts of a wide variety of military, commercial, and homemade explosives, as well as drugs. Featuring a radioactive material-free design, push-button maintenance and diagnostics, and internal automatic self-calibration, the QS-B220 brings new levels of performance and convenience to desktop trace detection users with unsurpassed ease of use.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    L3Harris Technologies, Inc.. (2019, February 24). Nigerian Company Procures Implant Sciences’ Handheld Explosives Trace Detectors. AZoSensors. Retrieved on November 21, 2024 from https://www.azosensors.com/news.aspx?newsID=4986.

  • MLA

    L3Harris Technologies, Inc.. "Nigerian Company Procures Implant Sciences’ Handheld Explosives Trace Detectors". AZoSensors. 21 November 2024. <https://www.azosensors.com/news.aspx?newsID=4986>.

  • Chicago

    L3Harris Technologies, Inc.. "Nigerian Company Procures Implant Sciences’ Handheld Explosives Trace Detectors". AZoSensors. https://www.azosensors.com/news.aspx?newsID=4986. (accessed November 21, 2024).

  • Harvard

    L3Harris Technologies, Inc.. 2019. Nigerian Company Procures Implant Sciences’ Handheld Explosives Trace Detectors. AZoSensors, viewed 21 November 2024, https://www.azosensors.com/news.aspx?newsID=4986.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.